Fabian Rodas Ochoa, MD, transplant hepatologist and clinical assistant professor of medicine at UT...
Read More
Survodutide has an “acceptable safety profile” in patients with metabolic dysfunction-associated steatohepatitis with compensated and decompensated cirrhosis,...
Texas Liver Institute’s Dr. Eric Lawitz and colleagues publish clinical trial results on 2...
Learn a little about the history of liver transplantation and exciting emerging areas in...
Reference: https://www.universityhealth.com/news/university-health-transplant-institute-named-best-liver-transplant-program-in-country
Listen to Dr. Rodas discuss the management of non-alcoholic fatty liver disease in patients...
TLI’s own Drs. Lawitz and Poordad were recently recognized for their scientific contributions to...